|
Hob Biotech Group Corp., Ltd (688656.SS) DCF -Bewertung
CN | Healthcare | Medical - Devices | SHH
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
HOB Biotech Group Corp.,Ltd (688656.SS) Bundle
Verbessern Sie Ihre Anlagestrategie mit der Hob Biotech Group Corp., Ltd. (688656S) DCF -Taschenrechner! Erforschen Sie authentische Finanzdaten, passen Sie Wachstumsprojektionen und -kosten an und beobachten Sie, wie sich Modifikationen in Echtzeit auf den inneren Wert der Hobbiotech Group Corp., Ltd. (688656Ss) auswirken.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 259.1 | 221.9 | 317.7 | 320.4 | 394.4 | 446.4 | 505.3 | 572.0 | 647.4 | 732.9 |
| Revenue Growth, % | 0 | -14.38 | 43.2 | 0.8449 | 23.1 | 13.19 | 13.19 | 13.19 | 13.19 | 13.19 |
| EBITDA | 89.0 | 83.5 | 124.9 | 86.4 | 98.7 | 145.8 | 165.0 | 186.8 | 211.4 | 239.3 |
| EBITDA, % | 34.34 | 37.65 | 39.31 | 26.95 | 25.02 | 32.66 | 32.66 | 32.66 | 32.66 | 32.66 |
| Depreciation | 14.3 | 16.5 | 26.0 | 37.8 | 39.5 | 38.4 | 43.4 | 49.2 | 55.6 | 63.0 |
| Depreciation, % | 5.51 | 7.46 | 8.19 | 11.79 | 10.02 | 8.6 | 8.6 | 8.6 | 8.6 | 8.6 |
| EBIT | 74.7 | 67.0 | 98.9 | 48.6 | 59.2 | 107.4 | 121.6 | 137.6 | 155.8 | 176.3 |
| EBIT, % | 28.83 | 30.2 | 31.12 | 15.16 | 15 | 24.06 | 24.06 | 24.06 | 24.06 | 24.06 |
| Total Cash | 90.8 | 58.8 | 454.9 | 289.0 | 163.5 | 261.8 | 296.3 | 335.4 | 379.7 | 429.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 20.3 | 29.9 | 37.5 | 32.4 | 45.4 | 48.9 | 55.3 | 62.6 | 70.9 | 80.2 |
| Account Receivables, % | 7.84 | 13.48 | 11.8 | 10.11 | 11.52 | 10.95 | 10.95 | 10.95 | 10.95 | 10.95 |
| Inventories | 59.6 | 61.9 | 68.2 | 87.8 | 111.2 | 114.3 | 129.4 | 146.4 | 165.8 | 187.6 |
| Inventories, % | 23.01 | 27.92 | 21.47 | 27.4 | 28.2 | 25.6 | 25.6 | 25.6 | 25.6 | 25.6 |
| Accounts Payable | 5.9 | 7.5 | 11.1 | 48.3 | 23.9 | 27.1 | 30.6 | 34.7 | 39.2 | 44.4 |
| Accounts Payable, % | 2.26 | 3.39 | 3.5 | 15.08 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 |
| Capital Expenditure | -34.8 | -57.0 | -167.9 | -220.2 | -178.0 | -183.8 | -208.0 | -235.5 | -266.5 | -301.7 |
| Capital Expenditure, % | -13.43 | -25.7 | -52.84 | -68.73 | -45.14 | -41.17 | -41.17 | -41.17 | -41.17 | -41.17 |
| Tax Rate, % | 16.41 | 16.41 | 16.41 | 16.41 | 16.41 | 16.41 | 16.41 | 16.41 | 16.41 | 16.41 |
| EBITAT | 64.8 | 58.3 | 86.0 | 43.5 | 49.4 | 93.2 | 105.5 | 119.4 | 135.2 | 153.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -29.8 | 7.6 | -66.1 | -116.2 | -150.0 | -55.6 | -77.0 | -87.2 | -98.7 | -111.7 |
| WACC, % | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -363.5 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | -116 | |||||||||
| Terminal Value | -8,879 | |||||||||
| Present Terminal Value | -6,856 | |||||||||
| Enterprise Value | -7,219 | |||||||||
| Net Debt | -112 | |||||||||
| Equity Value | -7,107 | |||||||||
| Diluted Shares Outstanding, MM | 64 | |||||||||
| Equity Value Per Share | -111.11 |
What You Will Receive
- Genuine HOB Biotech Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Automated Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Explore various scenarios to assess HOB Biotech's future performance.
- User-Friendly Design: Crafted for professionals while remaining approachable for newcomers.
Key Features
- 🔍 Real-Life HOB Biotech Financials: Pre-filled historical and projected data for HOB Biotech Group Corp., Ltd (688656SS).
- ✏️ Fully Customizable Inputs: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Integrated formulas compute HOB Biotech’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: See HOB Biotech’s valuation update immediately after adjustments.
- Scenario Analysis: Evaluate and contrast outcomes for different financial assumptions side-by-side.
How It Operates
- Step 1: Download the Excel file.
- Step 2: Examine the pre-filled HOB Biotech Group Corp., Ltd (688656SS) data (both historical and projected).
- Step 3: Modify the key assumptions (highlighted in yellow) according to your analysis.
- Step 4: Observe the automatic recalculations for HOB Biotech Group Corp., Ltd (688656SS)'s intrinsic value.
- Step 5: Utilize the results for your investment decisions or reporting needs.
Why Choose HOB Biotech Group's Calculator?
- All-Inclusive Tool: Combines DCF, WACC, and financial ratio analyses into a single resource.
- Flexible Inputs: Modify yellow-highlighted fields to explore different scenarios.
- In-Depth Analysis: Automatically determines the intrinsic value and Net Present Value for HOB Biotech Group (688656SS).
- Ready-to-Use Data: Incorporates historical and projected data for precise calculations.
- High-Caliber Quality: Perfect for financial analysts, investors, and business consultants.
Who Can Benefit from This Product?
- Individual Investors: Gain insights to make educated decisions regarding the purchase or sale of HOB Biotech Group Corp., Ltd (688656SS) stock.
- Financial Analysts: Enhance valuation methodologies with accessible financial models tailored for HOB Biotech Group Corp., Ltd (688656SS).
- Consultants: Provide clients with rapid and precise valuation analyses related to HOB Biotech Group Corp., Ltd (688656SS).
- Business Owners: Learn how the valuation of large biotech firms like HOB Biotech Group Corp., Ltd (688656SS) can inform your own business strategies.
- Finance Students: Explore real-world data and scenarios to master valuation techniques in the biotech sector, focusing on HOB Biotech Group Corp., Ltd (688656SS).
Overview of the Template Components
- Pre-Filled DCF Model: HOB Biotech’s financial data preloaded for immediate application.
- WACC Calculator: Comprehensive calculations for Weighted Average Cost of Capital.
- Financial Ratios: Assess HOB Biotech’s profitability, leverage, and operational efficiency.
- Editable Inputs: Adjust variables such as growth rates, profit margins, and CAPEX according to your scenarios.
- Financial Statements: Annual and quarterly reports provided for in-depth analysis.
- Interactive Dashboard: Intuitively visualize key valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.